ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group

February 28, 1997

ACCC Joins ONS In Opposing RCT Caregiver Category

March 31, 1989

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

New Research Grant Awards

December 13, 1974

Stanley Reimann: How One Man Saved a Research Institute

October 28, 2021